noom microdosing glp-1 expands its range with 'microdose' package Noom Launches $119 Microdose GLP-1

Patients treated with these medications can develop several skin reactions, including injection-site reactions, hypersensitivity responses, pruritus, rashes, and immune-mediated skin disorders such as psoriasis (Pso) and hidradenitis suppurativa (HS) [14,17,18,19,20]

Each card has a monthly savings cap

Wien Klin Wochenschr , 131

Key Takeaways Triple agonist mechanism: Retatrutide is the first medication to activate GIP, GLP-1, and glucagon receptors simultaneously GLP-1 component reduces appetite and slows gastric emptying, the core appetite suppression pathway GIP component improves insulin sensitivity and promotes favorable fat distribution Glucagon component increases energy expenditure through thermogenesis and promotes fat breakdown Weight loss: Phase 2 trials showed up to 24.2% weight loss at 48 weeks, compared to tirzepatide (~22%) and semaglutide (~15%) Investigational status: Not FDA-approved

Strategies to relieve dry mouth include staying hydrated, avoiding tobacco products, eating moist (not dry) foods, and considering over-the-counter and prescription aids that improve saliva production